COST
58
-2
LUV
39
-5
MA
55
-7
IBM
54
4
SO
55
-2
EIX
77
2
SWK
56
-2
VTR
49
-3
MS
74
-2
BEN
45
3
EOG
58
2
CVX
46
5
NWL
44
-4
USB
50
2
HD
47
-5
ADP
64
2
PPL
54
2
DE
46
3
UA
45
-3
FOXA
55
9
COST
58
-2
LUV
39
-5
MA
55
-7
IBM
54
4
SO
55
-2
EIX
77
2
SWK
56
-2
VTR
49
-3
MS
74
-2
BEN
45
3
EOG
58
2
CVX
46
5
NWL
44
-4
USB
50
2
HD
47
-5
ADP
64
2
PPL
54
2
DE
46
3
UA
45
-3
FOXA
55
9
Financhill
Back

Black Diamond Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

BDTX
Black Diamond Therapeutics

Last Price:
2.40
Seasonality Move:
21.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Black Diamond Therapeutics Price Quote

$2.40
-0.03 (-1.23%)
(Updated: November 21, 2024 at 2:15 PM ET)

Black Diamond Therapeutics Key Stats

Sell
34
Black Diamond Therapeutics (BDTX) is a Sell
Day range:
$2.38 - $2.56
52-week range:
$2.12 - $7.66
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.45%
Volume:
468.9K
Avg. volume:
647.2K
1-year change:
8%
Market cap:
$141.5M
Revenue:
$0
EPS:
$-1.33

How Much Does Black Diamond Therapeutics Make?

Data Unavailable

Is Black Diamond Therapeutics Growing As A Company?

Data Unavailable

Black Diamond Therapeutics Stock Price Performance

What Is Black Diamond Therapeutics 52-Week High & Low?

Black Diamond Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Black Diamond Therapeutics?

Is Black Diamond Therapeutics Cash Flow Positive?

  • What Is BDTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$61.2M
  • What Is Black Diamond Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $25.2M
  • What Is Black Diamond Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.4M

Black Diamond Therapeutics Return On Invested Capital

Data Unavailable

Black Diamond Therapeutics Earnings Date & Stock Price

Black Diamond Therapeutics Competitors

Black Diamond Therapeutics Dividend Yield

Black Diamond Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.5%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.50
Upside from Last Price: 496.71%

Major Shareholders

  • How many BDTX shares are owned by institutional investors?
    95.4M BDTX shares are owned by institutional investors
  • How many BDTX shares are owned by insiders?
    1.2M BDTX shares are owned by insiders